Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma

Xin Li(Shanghai University of Traditional Chinese Medicine), Shenglan Tan
Journal of Cancer
January 1, 2021
Cited by 14


Related Papers